Psychiatric Disorders During Pregnancy

The Next MGH Online Course on Women’s Mental Health Starts February 10, 2020

We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series.  Thank you for those [...]

If We Are So Concerned About Maternal Mental Health, Why Don’t We Have More Mother-Baby Mental Health Programs? 

The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, validated [...]

Prenatal Exposure to Maternal Depression and SSRIs Affect Network Connectivity, But in Different Ways

While we have considerable data regarding the reproductive safety of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs), most studies have focused on the prevalence of major malformations in children with prenatal exposure to antidepressants.  [...]

Ushering in the New Year, Looking Back at 2019

We hope everybody is settling into the New Year.  Here's a look back at what happened in 2019. Brexanolone takes the lead as our top story for 2019.  Brexanolone (introduced as SAGE-547 by SAGE Therapeutics) [...]

The Next MGH Online Course on Women’s Mental Health Starts February 10, 2020

We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series.  Thank you for those [...]

A Meta-Analysis of Gestational Diabetes and Risk for Perinatal Depression

According to recent findings published in Diabetic Medicine, women who develop gestational diabetes may be more likely to experience depression during pregnancy and after delivery, compared to women without gestational diabetes. Over the years, we [...]

Maternal Anxiety and Adverse Perinatal Outcomes: Why We Need to Screen Women for Anxiety During Pregnancy

When providing information to patients regarding the use of medications during pregnancy, one key element of the decision-making process is an appraisal of the risks associated with untreated psychiatric illness in the mother.  While there [...]